Earnings & Reporting

The firm beat Q4 revenue guidance but faces a soft outlook, doubling down on a futuristic AI strategy and aggressive shareholder returns to navigate volatility.

Amid stock swings, AtlasClear uses a video series to detail its dramatic financial turnaround and strategic acquisition plans to build investor trust.

Cindy Eckert's TIME100 nod follows a major FDA win for her libido drug, Addyi, but spotlights a decade-long battle over efficacy, safety, and equality.

Princess Cruises unveils patriotic voyages for America's 250th, its largest-ever Alaska season, a new ship, and a major sale for 2026 travel.

Australian fintech Valiant Finance hires a 30-year industry veteran to lead its charge into the $1.3 trillion US equipment finance sector with embedded tech.

Activist investor Starboard Value seeks to oust Tripadvisor's board, citing underperformance. The travel giant pushes back, touting a new strategy.

Toyota's new 375-hp bZ Woodland EV blends all-wheel-drive power, off-road grit, and family-friendly tech, aiming to be the practical adventurer's SUV.

A new AI shopping agent powered by 20 years of data promises to end sizing guesswork. Can it solve e-commerce's most expensive problem for good?

A new survey shows teens are unfazed by AI's career impact, but experts and economic data paint a far more complex and challenging picture.

A new survey reveals drivers underestimate annual car costs by over $4,500, a miscalculation that is reshaping household budgets and the auto industry.

ETST announces a major restructuring with executive pay cuts and portfolio changes, projecting $1.4M in savings and positioning for institutional investment.

Following record earnings, the diversified tech firm will outline its future in security, healthcare, and optoelectronics for investors and analysts.

Facing financial headwinds, the timeshare giant appoints a new CEO and COO with a bold, performance-based plan to revitalize growth and shareholder value.

Accord Healthcare's launch of generic lenalidomide signals a new era of affordability for a key cancer drug, intensifying competition and lowering costs.

Eagle Point Credit Co. slashes its dividend after reporting major losses but counters with a $100M buyback and a strategic shift beyond CLO equity.

Pangaea Logistics declared a $0.05 dividend, but what does this move signal about the company's health and the broader dry bulk market's future?

Nakamoto Inc. acquires Bitcoin Magazine's parent and a key investment firm in an all-stock deal, raising questions about market influence and shareholder value.

With its burn treatment gaining traction and a pivotal wound care drug in late-stage trials, MediWound prepares to make its case to Wall Street.

Agricultural supplier Farmmi Inc. stuns with a new AI marketing unit, Bluesage, that signed a global client in just two weeks. Is this the future?

Shutterstock posts record 2025 revenue on AI data growth, but a steep Q4 loss and merger costs reveal deep challenges in its core content business.